Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization - PubMed (original) (raw)
. 2005 Mar 4;280(9):8387-96.
doi: 10.1074/jbc.M408048200. Epub 2004 Nov 10.
Affiliations
- PMID: 15537645
- DOI: 10.1074/jbc.M408048200
Free article
Analysis of HIV-1 viral infectivity factor-mediated proteasome-dependent depletion of APOBEC3G: correlating function and subcellular localization
Michael J Wichroski et al. J Biol Chem. 2005.
Free article
Abstract
To study how HIV-1 viral infectivity factor (Vif) mediates proteasome-dependent depletion of host factor APOBEC3G, functional and nonfunctional Vif-APOBEC3G interactions were correlated with subcellular localization. APOBEC3G localized throughout the cytoplasm and co-localized with gamma-tubulin, 20 S proteasome subunit, and ubiquitin at punctate cytoplasmic bodies that can be used to monitor the Vif-APOBEC3G interaction in the cell. Through immunostaining and live imaging, we showed that a substantial fraction of Vif localized to the nucleus, and this localization was impaired by deletion of amino acids 12-23. When co-expressed, Vif exhibited more pronounced localization to the cytoplasm and reduced the total cellular levels of APOBEC3G but rarely co-localized with APOBEC3G at cytoplasmic bodies. On the contrary, Vif(C114S), which is inactive but continues to interact with APOBEC3G, stably associated with APOBEC3G in the cytoplasm, resulting in complete co-localization at cytoplasmic bodies and a dose-dependent exclusion of Vif(C114S) from the nucleus. Following proteasome inhibition, cytoplasmic APOBEC3G levels increased, and both proteins co-accumulated nonspecifically into a vimentin-encaged aggresome. Furthermore in the presence or absence of APOBEC3G, Vif localization was significantly altered by proteasome inhibition, suggesting that aberrant localization may also contribute to the loss of Vif function. Finally mutations at Vif Ile(9) disrupted the ability of Vif or Vif(C114S) to coimmunoprecipitate and to co-localize with APOBEC3G, suggesting that the N terminus of Vif mediates interactions with APOBEC3G. Taken together, these results demonstrate that cytoplasmic Vif-APOBEC3G interactions are required but are not sufficient for Vif to modulate APOBEC3G and can be monitored by co-localization in vivo.
Similar articles
- Vif overcomes the innate antiviral activity of APOBEC3G by promoting its degradation in the ubiquitin-proteasome pathway.
Mehle A, Strack B, Ancuta P, Zhang C, McPike M, Gabuzda D. Mehle A, et al. J Biol Chem. 2004 Feb 27;279(9):7792-8. doi: 10.1074/jbc.M313093200. Epub 2003 Dec 13. J Biol Chem. 2004. PMID: 14672928 - Influence of primate lentiviral Vif and proteasome inhibitors on human immunodeficiency virus type 1 virion packaging of APOBEC3G.
Liu B, Yu X, Luo K, Yu Y, Yu XF. Liu B, et al. J Virol. 2004 Feb;78(4):2072-81. doi: 10.1128/jvi.78.4.2072-2081.2004. J Virol. 2004. PMID: 14747572 Free PMC article. - Ubiquitination of APOBEC3G by an HIV-1 Vif-Cullin5-Elongin B-Elongin C complex is essential for Vif function.
Kobayashi M, Takaori-Kondo A, Miyauchi Y, Iwai K, Uchiyama T. Kobayashi M, et al. J Biol Chem. 2005 May 13;280(19):18573-8. doi: 10.1074/jbc.C500082200. Epub 2005 Mar 21. J Biol Chem. 2005. PMID: 15781449 - Cellular interactions of virion infectivity factor (Vif) as potential therapeutic targets: APOBEC3G and more?
Carr JM, Davis AJ, Feng F, Burrell CJ, Li P. Carr JM, et al. Curr Drug Targets. 2006 Dec;7(12):1583-93. doi: 10.2174/138945006779025356. Curr Drug Targets. 2006. PMID: 17168833 Review. - HIV-1 Vif: HIV's weapon against the cellular defense factor APOBEC3G.
Kremer M, Schnierle BS. Kremer M, et al. Curr HIV Res. 2005 Oct;3(4):339-44. doi: 10.2174/157016205774370456. Curr HIV Res. 2005. PMID: 16250885 Review.
Cited by
- Characterization of an A3G-VifHIV-1-CRL5-CBFβ Structure Using a Cross-linking Mass Spectrometry Pipeline for Integrative Modeling of Host-Pathogen Complexes.
Kaake RM, Echeverria I, Kim SJ, Von Dollen J, Chesarino NM, Feng Y, Yu C, Ta H, Chelico L, Huang L, Gross J, Sali A, Krogan NJ. Kaake RM, et al. Mol Cell Proteomics. 2021;20:100132. doi: 10.1016/j.mcpro.2021.100132. Epub 2021 Aug 11. Mol Cell Proteomics. 2021. PMID: 34389466 Free PMC article. - The von Hippel-Lindau Cullin-RING E3 ubiquitin ligase regulates APOBEC3 cytidine deaminases.
Scholtes GK, Sawyer AM, Vaca CC, Clerc I, Roh M, Song C, D'Aquila RT. Scholtes GK, et al. Transl Res. 2021 Nov;237:1-15. doi: 10.1016/j.trsl.2021.05.002. Epub 2021 May 15. Transl Res. 2021. PMID: 34004371 Free PMC article. - Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCFcyclin F E3 Ligase Machinery.
Augustine T, Chaudhary P, Gupta K, Islam S, Ghosh P, Santra MK, Mitra D. Augustine T, et al. J Biol Chem. 2017 Mar 31;292(13):5349-5363. doi: 10.1074/jbc.M116.765842. Epub 2017 Feb 9. J Biol Chem. 2017. PMID: 28184007 Free PMC article. - Feline Immunodeficiency Virus Vif N-Terminal Residues Selectively Counteract Feline APOBEC3s.
Gu Q, Zhang Z, Cano Ortiz L, Franco AC, Häussinger D, Münk C. Gu Q, et al. J Virol. 2016 Nov 14;90(23):10545-10557. doi: 10.1128/JVI.01593-16. Print 2016 Dec 1. J Virol. 2016. PMID: 27630243 Free PMC article. - Functional characterization of Vif proteins from HIV-1 infected patients with different APOBEC3G haplotypes.
Reddy K, Ooms M, Letko M, Garrett N, Simon V, Ndung'u T. Reddy K, et al. AIDS. 2016 Jul 17;30(11):1723-9. doi: 10.1097/QAD.0000000000001113. AIDS. 2016. PMID: 27064995 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources